• Latest Posts

Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma

Consortium awarded €4M towards platform for personalized cell therapies

First patient receives new immunotherapy drug for HIV in clinical trial

Evotec completes acquisition of Rigenerand

Scancell to produce and clinically validate T cell redirecting bispecific antibodies

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

ADVERTISEMENT

Boost for dementia gene-based therapies

TILT Biotherapeutics raises $10M to push ahead on cancer immunotherapies

Athersys to restructure – 70% of workforce to go

Evotec adds cell therapy manufacturing facility through Rigenerand takeover

Sponsored by 10 Mar 2022

Combination Therapies: Opportunities for Improved CAR-T Cell Therapy?

Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture

ADVERTISEMENT